SCHEMBL19806092

SCHEMBL19806092

COc1ccc(-c2nc(SC)nc3ccccc23)cn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 2/20 0.48
ADORA1 P30542 1/20 0.48
MAPT P10636 5/20 0.47
ALDH1A1 P00352 4/20 0.47
SMN1; SMN2 Q16637 3/20 0.47
KDM4E B2RXH2 8/20 0.45
KDM1A O60341 1/20 0.44
LMNA P02545 2/20 0.43
HTT P42858 2/20 0.43
ACP1 P24666 1/20 0.43
L3MBTL1 Q9Y468 3/20 0.43
TDP1 Q9NUW8 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
HPGD P15428 1/20 0.40
PDGFRB P09619 1/20 0.40
PDGFRA P16234 1/20 0.40
MEN1 O00255 1/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19806090 0.81 KDM4E (0.58) ADORA2AMAPTALDH1A1KDM4EKDM1A
SCHEMBL20203648 0.78 KDM4E (0.67) ADORA2AMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL8819450 0.77 KDM1A (0.45) ADORA2AKDM1AACP1L3MBTL1MEN1
SCHEMBL8818302 0.72 KDM1A (0.44) ADORA2AMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL8818590 0.72 KDM1A (0.43) ADORA2AKDM1AACP1L3MBTL1MEN1
SCHEMBL1422182 0.69 HSD17B1 (0.67) ADORA2AADORA1MAPTLMNAPDGFRB
SCHEMBL19806093 0.69 KDM4E (0.47) ADORA2AMAPTALDH1A1SMN1; SMN2KDM4E
SCHEMBL4494425 0.68 ADORA2A (0.50) ADORA2AADORA1MAPTPDGFRBPDGFRA
SCHEMBL19805990 0.68 ADORA2A (0.50) ADORA2AADORA1MAPTALDH1A1L3MBTL1
SCHEMBL5820464 0.67 HSD17B1 (0.51) MAPTALDH1A1SMN1; SMN2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-11725000-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2023-08-15 US disclosed
US-11034680-B2 Apoptosis inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2021-06-15 US disclosed
EP-3484854-B1 APOPTOSIS INHIBITORS NAT INSTITUTE OF BIOLOGICAL SCIENCES BEIJING (CN) 2021-01-20 EP disclosed
US-20190152960-A1 Apoptosis Inhibitors NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2019-05-23 US disclosed
WO-2018014802-A1 APOPTOSIS INHIBITORS NATIONAL INSTITUTE OF BIOLOGICAL SCIENCES, BEIJING (CN) 2018-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152960-A1 Apoptosis Inhibitors BAX, SDHA, SDHB ADORA2A 4749/4885ADORA1 4797/4885MAPT 2304/4885
US-11725000-B2 Apoptosis inhibitors BAX, SDHA, SDHB ADORA2A 4749/4885ADORA1 4797/4885MAPT 2304/4885
US-11034680-B2 Apoptosis inhibitors BAX, SDHA, SDHB ADORA2A 4749/4885ADORA1 4797/4885MAPT 2304/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.